Effects of valproic acid, carbamazepine, and phenobarbitone on the fatty acid composition of erythrocyte membranes in children

Epilepsia

Volumn 44, Issue 5, 2003, Pages 708-711

  König, Stephan A ^a   Knolle, Julia ^a   Friedewald, Steffen ^a   Koelfen, Wolfgang ^a   Longin, Elke ^a   Lenz, Tamara ^b   Hannak, Dieter ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF MANNHEIM   (Germany)

Author keywords

Antiepileptic drugs; Carbamazepine; Fatty acid; Membrane; Valproic acid

Indexed keywords

CARBAMAZEPINE; FATTY ACID; PHENOBARBITAL; VALPROIC ACID;

ADOLESCENT; ADULT; ANTICONVULSANT THERAPY; ARTICLE; CAPILLARY GAS CHROMATOGRAPHY; CHILD; CONTROLLED STUDY; DRUG EFFECT; EPILEPSY; ERYTHROCYTE MEMBRANE; HUMAN; LIPID COMPOSITION; LIPID MEMBRANE; MAJOR CLINICAL STUDY; MEAN CORPUSCULAR VOLUME; MONOTHERAPY; PRIORITY JOURNAL;

ADOLESCENT; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; CHILD, PRESCHOOL; EPILEPSY; ERYTHROCYTE MEMBRANE; FATTY ACIDS; FEMALE; HUMANS; INFANT; MALE; PHENOBARBITAL; REFERENCE VALUES; VALPROIC ACID;

EID: 17144451259     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2003.09802.x     Document Type: Article

References (17)

1. Sözüer DT, Atakli D, Dogu O, et al. Serum lipids in epileptic children treated with carbamazepine and valproate. Eur J Pediatr 1997;156:565-7.
2. Isojarvi JIT, Pakarinen AJ, Myllyla VV. Serum lipid levels during carbamazepine medication: a prospective study. Arch Neurol 1993;50:590-3.
3. Van den Berg RJ, Kok P, Voskuyl RA. Valproate and sodium currents in cultured hippocampal neurons. Exp Brain Res 1993;93:279-87.
4. Yamamoto R, Yanagita T, Kobayashi H, et al. Up-regulation of sodium channel subunit mRNAs and their cell surface expression by antiepileptic valproic acid: activation of calcium channel and catecholamine secretion in adrenal chromaffin cells. J Neurochem 1997;68:1655-62.
5. Lepage G, Roy CC. Improved recovery of fatty acid through direct transesterification without prior extraction or purification. J Lipid Res 1984;25:1391-6.
6. Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 1986;275:114-20.
7. Connor WE, Lin DS, Neuringer M. Is the docosahexaenoic acid (DHA) content of erythrocytes a marker for the DHA content of brain phospholipids? FASEB J 1993;7:A152.
8. Decsi T, Koletzko B. Fatty acid composition of plasma lipid classes in healthy subjects from birth to young adulthood. Eur J Pediatr 1994;153:520-5.
9. Lehninger AL. Biochemistry. New York: Worth Publishers, 1975:279-308.
10. Yehuda S, Carasso RL, Mostofsky DI. Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. Eur J Pharmacol 1994;254:193-8.
11. Ordway RW, Singer JJ, Walsh JV Jr. Direct regulation of ion channels by fatty acids. Trends Neurosci 1991;14:96-100.
12. Kirber MT, Ordway RW, Clapp LH, et al. Voltage, ligand, and mechanically gated channels in freshly dissociated single smooth muscle cells. Prog Clin Biol Res 1988;334:123-43.
13. Woods BT, Chiu TM. Fatty acid elevation and brain seizure activity. TINS 1991;14:405.
14. Perlman BJ, Goldstein DB. Membrane-disordering potency and anticonvulsant action of valproic acid and other short-chain fatty acids. Am Soc Pharm Exp Ther 1984;40:83-9.
15. Turnbull DM, Rawlins MD, Weightman D, et al. A comparison of phenytoin and valproate in previously untreated adult epileptic patients. J Neurol Neurosurg Psychiatry 1982;45:55-9.
16. Knupfer MM, Hernaiz-Driever P, Poppenburg H, et al. Valproic acid inhibits proliferation and changes expression of CD44 and CD56 of malignant glioma cells in vitro. Anticancer Res 1998;18:3585-9.
17. Driever PH, Knupfer MM, Cinatl J, et al. Valproic acid for the treatment of pediatric malignant glioma. Klin Pädiatr 1999;211:323-8.